Skip to main content
Epocrates Online
Contact us
Explore features
Reach clinicians
Buy now
By
vgreene
, 9 June, 2020
Palonosetron + dexamethasone + olanzapine1-3
By
vgreene
, 9 June, 2020
5-HT3 RA + NK1 RA + dexamethasone + oilanzapine1,2
By
vgreene
, 9 June, 2020
5-HT3 RA + NK1 RA + dexamethasone1-3
By
vgreene
, 9 June, 2020
Start before chemotherapy on day 1
By
vgreene
, 9 June, 2020
Oral chemotherapy
By
vgreene
, 9 June, 2020
Parenteral chemotherapy
By
vgreene
, 9 June, 2020
Minimal-emetic risk chemotherapy
By
vgreene
, 9 June, 2020
Low-emetic risk chemotherapy
By
vgreene
, 9 June, 2020
Moderate-emetic risk chemotherapy
By
vgreene
, 9 June, 2020
High-emetic risk chemotherapy
Pagination
First page
Previous page
…
Page
1688
Page
1689
Page
1690
Page
1691
Current page
1692
Page
1693
Page
1694
Page
1695
Page
1696
…
Next page
Last page
About Us
Company Overview
Media Relations
Contact
Editorial Policy
Editorial Process
Third-Party Sponsorship Policy
athenahealth
Products
Core Products
Mobile CME
Product Licenses
Business Solutions
Pharma
Market Research
Institutions
Support
Support Center
Install
My Account
Stay Connected
Facebook
Twitter
YouTube